Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Adults 1 > hepatobiliary > Flashcards

hepatobiliary Flashcards

1
Q

hepatobiliary disorders

A

cholecystitis, cholelithiasis, jaundice, portal HTN, ascites, hepatic encephalopathy, esophageal varices, cirrhosis, hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cholecystitis

A

inflammation of the gallbladder; acute or chronic; majority of acute cases are calculous cholecystitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

acalculous cholecystitis

A

inflammation without obstruction by gallstones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cholecystitis manifestations

A

pain, tenderness, rigidity of RUQ; may radiate to midsternal area or right shoulder; accompanied by N/V if acute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cholelithiasis

A

aka gallstones; calculi which are conatituenta of bile (75% of cases are made of cholesterol); more prevalent with increasing age; 2-3x more common in woment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

risk factors for developing cholelithiasis

A

CF, DM, frequent weight changes, estrogen therapy, obesity, rapid weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

clinical manifestations of cholelithiasis

A

may or may not be present; epigastric distress, abdominal distention, biliary colic, jaundice, dark urine, gray stool, vitamin deficiency (ADEK), vague RUQ/abdominal pain, pain may follow high fat meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

detecting cholelithiasis done via…

A

magnetic resonance cholangiopancreatography (MRCP) that can detect biliary tract obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

managing cholelithiasis

A

supportive care consists of rest, IV fluids, NG suction, analgesics, low fat diet (initially low fat liquid only); nonsurgical/surgical- lithotripsy is temporary solution infrequently used; laparoscopic cholecystectomy once s/s resolve; pharmacological agents to dissolve stones over months are rarely effective and recurrence is high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

interventions for cholelithiasis

A

post op- low fowlers, IV fluids, NG suction, clear fluids to soft dieat as bowel sounds return; pain relief, monitor resp. status, skin integrity and promotion of biliary drainage, nutritional status, monitor for complications such as infection or disruption in GI tract (anorexia, vomiting, fever, distension), educate pt on wound care diet resuming activity and pain management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

hepatic dysfunction

A

can be acute or chronic; chronic is the 12 leading cause of death in young-middle aged adults (40% d/t alcohol abuse); caused by infection, cirrhosis, liver failure d/t alcohol, fatty liver disease (nonalcoholic fatty liver disease or nonalcoholic steatohepatitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

clinical manifestations of hepatic dysfunction

A

jaundice, ascites, edema, N/V, loss of appetite, weight loss, encephalopathy, hand tremor (asterixis), easy bruising/spider angioma, HLD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hepatic dysfunction risk factors

A

excessive/prolonged alcohol intake, obesity 9excessive fat deposition), viral hepatitis, certain meds (NSAIDs), comorbidities like DM HTN autoimmune hepatitis; toxin exposure, old ager/genetic predisposition, unhealthy diet/sedentary lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

jaundice types

A

pre-hepatic- excessive breakdown of RBC overwhelms liver ability to process bilirubin; hepatic- livers impaired ability to process bilirubin, occurs in hepatitis cirrhosis and drug induced liver injury; post-hepatic- obstructive, blocked bile flow from liver to intestine that commonly occurs with gallstones tumors and bile duct disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

s/s of jaundice

A

yellowing of skin/eyes, dark urine d/t excess bilirubin excretion, pale/clay colored stool d/t lack of bilirubin in GI tract, pruritis; may include symptoms of hepatomegaly, splenomegaly, abd pain, fatigue/weakness, cognitive changes, and bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

portal HTN

A

increased BP within portal venous system which carries blood from digestive organs to live for detoxification, caused by cirrhosis, thrombosis, hepatitis, fatty liver disease, splenomegaly; diagnosed with imaging (US, CT, MRI), endoscopy for detecting varices, labs to assess liver function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

complications of portal HTN

A

varices- vessels developed in esophagus and stomach from increased pressure that can rupture and cause severe bleeding; ascites- increased pressure leads to fluid leakage from blood vessels into abdominal cavity; hepatic encephalopathy- elevated toxins bypassing liver can affect brain function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

managing portal HTN

A

treat the underlying liver disease, medication to reduce pressure, endoscopic procedures to address varices, severe cases require liver transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

portal HTN interventions

A

monitor VS and fluid balance, assess/manage variceal bleeding via vasoconstrictors, maintain airway and prevent asp., monitor neuro status (admin lactulose), manage ascites with diuretics and sodium restriction, nutritional support, psychosocial support, pt/fam education

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ascites clinical manifestations

A

increased abdominal girth, rapid weight gain, shortness of breath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ascites nursing interventions

A

negative sodium balance to reduce fluid retention (2g), administration of diuretics and monitoring fluid/electrolyte balance, prepare for paracentesis (up to 5-6L removed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

transjugular intrahepatic portosystemic shunt

A

cannula threaded through portal vein by transjugular route and placed between portal circulation and hepatic vein; decreases sodium retention and prevents recurrence of fluid accumulation that would result in ascites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

esophageal varices

A

varicosities developed from elevated pressure in veins that drain into portal system; prone to rupture and often cause massive hemorrhage; first hemorrhage has mortality rate of 10-30% and is one of the leading causes of death in pt with cirrhosis

24
Q

manifestations of esophageal varices

A

asymptomatic unless bleeding; otherwise hematemesis, melena, gen. deterioration in mental/physical status, HX of alcohol abuse, s/s of shock, endoscopy used to find site of bleeding

25
Q

managing esophageal varices

A

monitor for bleeding, admin of beta blockers to prevent first bleed by decreasing portal tension, admin of vasoactive drugs before endoscopy if bleeding, endoscopic sclerotherapy

26
Q

hepatic encephalopathy

A

accumulation of ammonia and other toxic metabolites in blood d/t hepatic insufficiency and portosystemic shunting; early signs are mental changes and motor disturbances; late signs are constructional ataxia, asterixis and fetor hepaticus

27
Q

assessment of hepatic encephalopathy

A

EEG, changes in LOC, potential seizures, fetor hepaticus, monitor fluid electrolyte and ammonia levels

28
Q

4 stages of hepatic encephalopathy

A
  1. normal level of consciousness with periods of lethargy and euphoria, reversal of day night sleep patterns; 2. increased drowsiness disorientation, inappropriate behavior, mood swings, and agitation; 3. stuporous, difficult to rouse, sleeps most of time, marked confusion, incoherent speech; 4. comatose, may not respond to painful stimuli
29
Q

managing hepatic encephalopathy

A

eliminate precipitating cause, lactulose to reduce serum ammonia, IV glucose to minimize protein catabolism, protein restriction, reduction of ammonia from GI tract via suction enema and oral antibx, discontinue sedatives analgesics and tranquilizers, monitor or treat complications/infections

30
Q

hepatic encephalopathy interventions

A

assess LOC changes, IOs, bodyweight, VS q4, serial daily ammonia levels and electrolytes, restricted dietary protein, GI tract suctioning, administer lactulose, monitor therapeutic response, monitor resp. status

31
Q

esophageal varices interventions

A

safe environment, prevent injury, prevent bleeding and infection, admin prescribed treatments, monitor for complications, encourage deep breathing and position changes, educate pt and fam

32
Q

treatment of bleeding varices

A

treat for shock, admin O2, IV fluids, electrolytes, volume expanders, blood and blood product, vasopressin, somatostatin, octreotide (decrease bleeding), nitroglycerin and vasopressin combo to reduce coronary vasoconstriction, propanolol and nadolol to decrease portal pressure, balloon tamponade

33
Q

hepatic cirrhosis

A

alcoholic: scar tissue characteristically surrounds portal areas; post-necrotic: broad bands of scar tissue; biliary: scarring occurs in the liver around bile ducts; hemochromatosis related; NAFLD/NASH related

34
Q

manifestations of compensated cirrhosis

A

ankle edema, firm and enlarged liver, intermittent mild fever, palmar erythema, splenomegaly, vascular spiders, vague morning indigestion

35
Q

uncompensated cirrhosis manifestations

A

ascites, clubbing of fingers, continuous fever, epistaxis, hypotension, jaundice, muscle wasting, purpura

36
Q

cirrhosis interventions

A

promote rest, improve nutrition, provide skin care, reduce risk of injury, monitor/manage potential complications

37
Q

cirrhosis complications

A

bleeding/hemorrhage, hepatic encephalopathy, fluid volume excess

38
Q

liver transplant interventions

A

preop- support, educate, encourage (psychologically); postop- monitor for infection, vascular complications, respiratory and liver dysfunction, monitor closely; caregiver support

39
Q

hepaptitis

A

viral- systemic viral infection causing necrosis and inflammation of liver cells with characteristic symptoms and cellular/biochemical changes; A/E: fecal-oral route; B/C: bloodborne; D: only people with B are at risk; nonviral- d/t drugs and medications

40
Q

hepatitis A

A

spread via poor hand hygiene; oral-fecal route; incubates in 2-6 weeks; ill ness last 4-8 weeks; acute only, doe not progress to chronic disease

41
Q

s/s of hepatitis A

A

asymptomatic, GI s/s, jaundice, dark urine, joint pain, fever, fatigue

42
Q

managing hepatitis A

A

prevention via handwashing, vaccine, immunoglobulin for contacts to provide passive immunity; bed rest during acute, nutritional support

43
Q

hepatitis B

A

transmitted via blood, saliva, vaginal secretions; is sexually transmitted; transmitted to infant at time of birth; acute and chronic result in cirrhosis and liver cancer; incubation is 1-6 months; risk factors are healthcare workers, birth, tattoo, IV drug use

44
Q

s/s Hepatitis B

A

flu like symptoms, arthralgias, jaundice, dark urine

45
Q

Hepatitis B diagnostic

A

+HBsAg/ anti-HBs

46
Q

managing hepatitis B

A

chronic meds: alpha interferon (subq) and antiviral agents (oral entecavir ETV + tenofovir TDF), bed rest, nutritional support, hand hygiene, vaccine of those at high risk, vaccination of infants; passive immunity for those exposed, standard precautions and infection control measures, screening of blood/blood products

47
Q

hepatitis C

A

transmitted via IV drug use, sex, and blood transfusions prior to 1992; most common bloodborne infection; 1/3 cause liver cancer (need transplant), incubates in 15-160 days, can be acute or chronic, risk factors are healthcare workers IV drug users and multiple sexual partners

48
Q

diagnostic for hepatitis C

A

anti-HCV (chronic)

49
Q

s/s of hepatitis C

A

flu like symptoms, jaundice, dark urine

50
Q

managing hepatitis C

A

antiviral meds like DAA, avoid alcohol, prevention via public health programs to decrease needle sharing, screening blood supply, safety needles for healthcare workers

51
Q

hepatitis D

A

only occurs with hep B; transmitted via blood, sex, IV drug use; HD/blood transfusions; can be acute or chronic;

52
Q

diagnostic for hepatitis D

A

anti HDV, HDsAg

53
Q

treatment for hepatitis D

A

interferon alfa

54
Q

hepatitis E

A

fecal- oral route, contaminated water; incubates in 15-65 days; resembles hepatitis A; self-limiting, abrupt onset, not chronic; prevention via good hygiene and handwashing

55
Q

other liver disorders are…

A

nonviral- toxic hepatitis and drug-induced hepatitis; fulminant hepatic failure can be caused by hepatitis

56
Q

liver transplant education

A

educate on long-term measures to promote health, adhere to therapeutic regimen, side effect of immunosuppressants; educate on s/s that indicate problems that require consult with transplant team; importance of follow up labs and appointment with transplant team

57
Q

ascites

A

caused by portal HTN which increases capillary pressure and causes obstruction of venous blood flow; failure to metabolize aldosterone causing increasing fluid and sodium retention and intravascular fluid; decreased albumin synthesis causing decreased serum oncotic pressure; movement of albumin causes fluid shifts to peritoneal cavity; vasodilation of splanchnic circulation

Adults 1 (10 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions